82 related articles for article (PubMed ID: 549256)
1. Hemodynamic effects of intravenous and oral amrinone in patients with severe heart failure: relationship between intravenous and oral administration.
LeJemtel TH; Keung EC; Schwartz WJ; Maskin CS; Greenberg MA; Davis RS; Forman R; Ribner HS; Sonnenblick EH
Trans Assoc Am Physicians; 1979; 92():325-33. PubMed ID: 549256
[No Abstract] [Full Text] [Related]
2. [Hemodynamic effects of various doses of a new inotropic: amrinoma].
Cárdenas M; Vidaurri A
Arch Inst Cardiol Mex; 1979; 49(5):961-8. PubMed ID: 122781
[TBL] [Abstract][Full Text] [Related]
3. Clinical effects of intravenous amrinone in patients with congestive heart failure.
Goldstein RA
Circulation; 1986 Mar; 73(3 Pt 2):III191-5. PubMed ID: 3510775
[TBL] [Abstract][Full Text] [Related]
4. Intravenous amrinone for congestive heart failure.
Med Lett Drugs Ther; 1984 Nov; 26(675):104-5. PubMed ID: 6390109
[No Abstract] [Full Text] [Related]
5. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
Hermiller JB; Leithe ME; Magorien RD; Unverferth DV; Leier CV
J Pharmacol Exp Ther; 1984 Feb; 228(2):319-26. PubMed ID: 6694112
[TBL] [Abstract][Full Text] [Related]
6. [Effects of amrinone administered orally and by injection in heart failure].
Bounhoure JP; Massabuau P; Puel J; Miquel JP; Calazel J
Ann Med Interne (Paris); 1985; 136(3):251-5. PubMed ID: 3896092
[TBL] [Abstract][Full Text] [Related]
7. Acute haemodynamic effects of intravenous amrinone in chronic congestive heart failure.
Bahl VK; Khalilullah M
Indian Heart J; 1984; 36(6):369-74. PubMed ID: 6535755
[No Abstract] [Full Text] [Related]
8. [Amrinone in acute and long-term therapy].
Klepzig M; Kleinhans E; Büll U; Strauer BE
Z Kardiol; 1985 Feb; 74(2):85-90. PubMed ID: 3922139
[TBL] [Abstract][Full Text] [Related]
9. Amrinone: a promising new cardiotonic agent in the treatment of chronic cardiac failure.
Likoff MJ; Weber KT; Andrews V; Janicki JS
Herz; 1983 Aug; 8(4):199-205. PubMed ID: 6413341
[No Abstract] [Full Text] [Related]
10. Failure of low doses of amrinone to produce sustained hemodynamic improvement in patients with severe chronic congestive heart failure.
Packer M; Medina N; Yushak M
Am J Cardiol; 1984 Nov; 54(8):1025-9. PubMed ID: 6496324
[TBL] [Abstract][Full Text] [Related]
11. Non-glycoside, non-catecholamine inotropic agents in the treatment of congestive heart failure.
Tommaso CL
Am J Med; 1986 Feb; 80(2B):36-9. PubMed ID: 3004210
[No Abstract] [Full Text] [Related]
12. Positive inotropic effect of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure.
Hashimoto K; Yabuuchi Y; Yamashita S; Mori T
Arzneimittelforschung; 1984; 34(3A):390-3. PubMed ID: 6540094
[TBL] [Abstract][Full Text] [Related]
13. Amrinone--a new inotropic agent in chronic resistant congestive cardiac failure.
Robinson PJ; Lvoff R; Chong B; Barrett PA
Aust N Z J Med; 1981 Dec; 11(6):666-8. PubMed ID: 6949545
[TBL] [Abstract][Full Text] [Related]
14. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
Saborowski F; Peters P; Schneider M
Z Kardiol; 1991; 80 Suppl 4():63-7. PubMed ID: 1833900
[TBL] [Abstract][Full Text] [Related]
15. [Hemodynamic and clinical effects and treatment tolerance with low-dose iv amrinone in patients with refractory heart failure: a multicenter study. The Group for Research on Amrinone in the Treatment of Refractory Heart Failure].
Dei Cas L; Metra M; Nodari S; Raddino R; Visioli O
Cardiologia; 1991 May; 36(5):363-71. PubMed ID: 1756541
[TBL] [Abstract][Full Text] [Related]
16. [Oral and injectable amrinone in cardiac insufficiency].
Massabuau P; Puel J; Miquel JP; Bounhoure JP
Ann Cardiol Angeiol (Paris); 1984; 33(4):223-6. PubMed ID: 6465816
[TBL] [Abstract][Full Text] [Related]
17. Haemodynamic effects of amrinone infusion in patients with chronic heart failure.
Manoharan S; Yadav BS; Tyagi S; Rao DK; Puri YK; Singh PP; Lochan R; Khalilullah M
Indian Heart J; 1986; 38(5):362-6. PubMed ID: 3570319
[No Abstract] [Full Text] [Related]
18. Pharmacokinetics of the bipyridines amrinone and milrinone.
Edelson J; Stroshane R; Benziger DP; Cody R; Benotti J; Hood WB; Chatterjee K; Luczkowec C; Krebs C; Schwartz R
Circulation; 1986 Mar; 73(3 Pt 2):III145-52. PubMed ID: 3510771
[TBL] [Abstract][Full Text] [Related]
19. Amrinone and exercise performance in patients with chronic heart failure.
Weber KT; Andrews V; Janicki JS; Wilson JR; Fishman AP
Am J Cardiol; 1981 Jul; 48(1):164-9. PubMed ID: 7246438
[No Abstract] [Full Text] [Related]
20. Chronic oral amrinone therapy in congestive heart failure: a double-blind placebo-controlled withdrawal study.
Evans JR; Pacht K; Huss P; Unverferth DV; Bashore TM; Leier CV
Int J Clin Pharmacol Res; 1984; 4(1):9-18. PubMed ID: 6381344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
